Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-11-07FDA Approved: FOSCAVIR — Supplemental Application (Clinigen Limited)
The FDA approved a supplemental application for FOSCAVIR (foscarnet sodium) from Clinigen Limited, authorizing changes to the product labeli…
-
FDA approval · 2014-11-04FDA Approved: VALGANCICLOVIR — Original Application (Strides Pharma Science Limited)
The FDA approved Strides Pharma Science Limited's original application for valganciclovir hydrochloride as a generic drug (Valganciclovir).
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus [Phase 1]
A Phase 1 study evaluating safety, toxicity and maximum tolerated dose of a single IV infusion of donor cytotoxic T lymphocytes specific for…
-
CLINICAL_TRIALS trial_result · 2014-10-08Clinical Trial Update: Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant [Phase 1]
This update reports the completion of a Phase 1 trial evaluating cytotoxic T-lymphocytes as a prophylaxis against cytomegalovirus infection …
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE) [Phase 1]
Phase 1 trial update on VIRAGE, rapidly generated multivirus-specific cytotoxic T-lymphocytes, for viral infections in the context of stem c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors [Phase 2]
Phase 2 trial evaluating accelerated immunization to induce cytomegalovirus immunity in stem cell donors; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-28Clinical Trial Update: A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial update of oral valganciclovir (Valcyte) in pediatric kidney transplant recipients with Cytomegalovirus infections; re…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections [Phase 1]
Phase 1 clinical trial update on the emergency use of donor lymphocytes to treat cytomegalovirus infection in patients who have undergone do…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Transfusion-Transmitted Cytomegalovirus Prevention in Neonates [Phase 3]
A Phase 3 clinical trial investigating prevention of transfusion-transmitted cytomegalovirus infection in neonates has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-01Clinical Trial Update: The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients [Phase 3]
This update reports on a Phase 3 trial evaluating the safety and effectiveness of adefovir dipivoxil in HIV-infected patients, including tho…
-
CLINICAL_TRIALS trial_result · 2013-09-09Clinical Trial Update: Cytomegalovirus Cell-Mediated Immunity
An update on a completed trial investigating cytomegalovirus cell-mediated immunity.
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial comparing T-lymphocyte infusion versus standard therapy to prevent cytomegalovirus infection in patients after donor …
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation [Phase 3]
Phase 3 trial comparing oral valganciclovir to placebo for prevention of cytomegalovirus infection after lung transplantation has completed …
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Clinical Evaluation of Ultrashort-term Heat Inactivation of Cytomegalovirus (CMV) Containing Raw Breast Milk to Prevent CMV-infection of Preterm Infants [NA]
This completed trial evaluated ultrashort-term heat inactivation of cytomegalovirus-containing raw breast milk to prevent CMV infection in p…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients
This clinical trial update reports on cell-mediated immunity and the risk of cytomegalovirus infection in solid organ transplant recipients,…
-
FDA approval · 2013-03-28FDA Approved: VALCYTE — Supplemental Application (H2-Pharma, LLC)
The FDA approved a supplemental application for VALCYTE (valganciclovir) submitted by H2-Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients
This completed clinical trial investigated how burn size affects cytomegalovirus reactivation and the relationship to T cell immune function…
-
CLINICAL_TRIALS research · 2012-12-20Clinical Trial Update: Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant Recipients
This clinical trial update examines whether replication of cytomegalovirus affects the recurrence of hepatitis C after liver transplantation…
-
CLINICAL_TRIALS trial_result · 2012-12-18Clinical Trial Update: The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS [Phase 2]
Phase 2 trial results assessing the safety and effectiveness of FIAC for cytomegalovirus infection in patients with AIDS.
-
CLINICAL_TRIALS research · 2012-08-08Clinical Trial Update: Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection [NA]
This source reports an update on a clinical trial evaluating the safety and efficacy of intravenous immunoglobulins in pregnant women with p…
-
CLINICAL_TRIALS trial_result · 2012-06-25Clinical Trial Update: Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants [Phase 1]
Phase 1 clinical trial evaluating a cytomegalovirus vaccine to prevent CMV infection in healthy participants has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients [NA]
A completed clinical trial investigating immune responses to cytomegalovirus infection in ICU patients.
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients
This completed clinical trial evaluated the QuantiFERON-CMV assay as a predictor of CMV infection in high-risk solid organ transplant recipi…
-
FDA approval · 2012-02-10FDA Approved: FOSCAVIR — Supplemental Application (Clinigen Limited)
FDA approved a supplemental application for FOSCAVIR (foscarnet sodium) submitted by Clinigen Limited.
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals
A completed clinical trial evaluating interferon-gamma responses to cytomegalovirus infection in HIV-positive individuals.